Review
Multi-drug resistant tuberculosis in context of RNTCP
Affiliations
- PMID: 12866642
Item in Clipboard
Review
Multi-drug resistant tuberculosis in context of RNTCP
Indian J Chest Dis Allied Sci.
2003 Jul-Sep.
Abstract
DOTS has been successful in improving cure rates in tuberculosis worldwide, but has remained an inefficient strategy in respect of multidrug-resistant tuberculosis (MDR TB). The present article discusses its management in context of RNTCP and focuses specially on DOTS-plus, a strategy arising out of the constitution of Green Light Committee to effectively tackle the cases of MDR TB globally.
Similar articles
-
Management of multidrug-resistant tuberculosis: Update 2007.Respirology. 2008 Jan;13(1):21-46. doi: 10.1111/j.1440-1843.2007.01180.x. Respirology. 2008. PMID: 18197909 Review.
-
Speaking the same language: treatment outcome definitions for multidrug-resistant tuberculosis.Int J Tuberc Lung Dis. 2005 Jun;9(6):640-5. Int J Tuberc Lung Dis. 2005. PMID: 15971391
-
Prevalence of drug resistance under the DOTS strategy in Hyderabad, South India, 2001-2003.Int J Tuberc Lung Dis. 2006 Jan;10(1):58-62. Int J Tuberc Lung Dis. 2006. PMID: 16466038
-
[Multidrug resistance tuberculosis - current problems].Pneumonol Alergol Pol. 2009;77(3):276-83. Pneumonol Alergol Pol. 2009. PMID: 19591099 Review. Polish.
-
Management of multi-drug resistant tuberculosis: practitioner's view point.Indian J Tuberc. 2007 Jan;54(1):3-11. Indian J Tuberc. 2007. PMID: 17455417 Review.